Structure Info
- Chemspace ID
- CSCS00000689949 (Synthesis)
- CAS
- 1188144-09-3, 113948-07-5
- MFCD
- MFCD11219513
- IUPAC Name
- 5,7-dichloro-2,3-dihydro-1H-inden-1-ol
- Mol formula
- C9H8Cl2O
- Mol weight
- 203 Da
- Catalog Number(s)
- AV47158, BB4LS-EN300-111225, BBV-32862137, BD765684, CS-0308223, CSC000689949, D439108, EN300-111225, F718325, HY-W264835, LN04544484, N13072, N13072-0.25G, NXB14409, PB815192144, Y3133003, Z815114676, ZXC290454
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.96
- Heavy atoms count
- 12
- Rotatable bond count
- 0
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.333
- Polar surface area (Å)
- 20
- Hydrogen bond acceptors count
- 1
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00000689949
Items Overall 11 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 97 | 250 mg | 901 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 97 | 1 g | 2,259 | |
Description: Name:5,7-Dichloro-2,3-dihydro-1H-inden-1-ol; CAS: 1188144-09-3 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 97 | 250 mg | 901 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 97 | 1 g | 2,259 | |
Description: Name:5,7-Dichloro-2,3-dihydro-1H-inden-1-ol; CAS: 1188144-09-3 | ||||||
| eNovation CN | 40 days | China To: | 95 | 50 mg | 362 | |
| eNovation CN | 40 days | China To: | 95 | 100 mg | 535 | |
| eNovation CN | 40 days | China To: | 95 | 250 mg | 742 | |
| eNovation CN | 40 days | China To: | 95 | 500 mg | 1,167 | |
| eNovation CN | 40 days | China To: | 95 | 1 g | 1,489 | |
Description: 5,7-dichloro-2,3-dihydro-1H-inden-1-ol; CAS: 1188144-09-3 | ||||||
| Astatech Inc | TBD | United States To: | 95 | 1 g | POA | |
| Zerenex Molecular Ltd | TBD | United Kingdom To: | 95 | 1 g | POA | |
Description: CAS: 1188144-09-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire